Select Medical Holdings Corporation (NYSE:SEM) is considered one of the best dividend stocks to buy, with an average price target suggesting a 34% upside and a Street high pointing to a 41% increase. Analyst Ben Hendrix from RBC Capital maintains a Buy rating with a $20 price target as of November 5. The company reported Q3 2025 results with revenue rising to $1,363.4 million, showing growth in critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation segments. Select Medical paid a cash dividend of $0.0625 per share on November 25 and announced a common share repurchase program worth up to $1 billion, extending until December 31, 2027. The company estimates total revenue for FY2025 between $5.3-$5.5 billion, Adjusted EBITDA of $510-$530 million, and diluted EPS of $1.14-$1.24. Select Medical operates hospitals and outpatient clinics in the U.S., specializing in various medical conditions and treatments. While SEM shows investment potential, other AI stocks may offer greater upside with less downside risk.

Read more at Yahoo Finance: Wall Street Sees a 41% Upside to Select Medical Holdings (SEM)